Researchers at the University of Vienna have developed fluorescent peptide tracers that can simultaneously visualize and activate the oxytocin receptor. This receptor—also known as the love/bonding hormone receptor—plays ...
Oct 1, 2025
0
0
The U.S. Food and Drug Administration has approved Eli Lilly's Inluriyo (imlunestrant), an oral estrogen receptor antagonist, for the treatment of adults with estrogen receptor-positive, human epidermal growth factor receptor ...
Oct 1, 2025
0
0
Harvard Medical School, Brigham and Women's Hospital, and Dell Medical School researchers report that rising rates of early-onset cancer in the United States may reflect more diagnoses rather than more disease.
A retrospective study found that the 313-SNP breast cancer polygenic risk score (PRS313) blood test could predict future incidents of breast cancer in women diagnosed with ductal carcinoma in situ (DCIS) or lobular carcinoma ...
Oct 1, 2025
0
3
Breast cancer survivors with severe menopausal symptoms should be supported to make an informed decision about whether to have hormone replacement therapy or not, according to an interdisciplinary panel of experts including ...
Sep 30, 2025
0
1
In experiments with mouse models of breast, pancreatic, and muscle cancers, researchers at Johns Hopkins All Children's Hospital report new evidence that a novel means of boosting the natural immune system prevents cancer ...
Sep 30, 2025
0
91
Ovarian cancer is known for its aggressive spread, often targeting fatty tissues in the abdomen. Now, a study published in Nature Communications by researchers at Karolinska Institutet and Queen Mary University of London ...
Sep 30, 2025
0
46
The first randomized trial to compare photon- and proton-based radiation therapy for breast cancer finds that patients report equally strong health-related quality of life with either treatment. Patients who received proton ...
Sep 29, 2025
0
0
Removing lymph nodes during cancer surgery has saved countless lives in many tumor types. Yet recent research is challenging parts of this long-standing practice.
Sep 29, 2025
0
0
A new randomized study finds that a lab test that reads tumor genes can identify which patients with recurrent prostate cancer will benefit from adding hormone therapy to radiation after surgery—the first predictive biomarker ...
Sep 28, 2025
0
0
